Top 200 Drugs And Indications

Front 1

Lipitor®

Back 1

Atorvastatin

Hint 1

antihyperlipidemic

Front 2

Singulair

Back 2

Montelukast

Hint 2

antiasthmatic

Front 3

Lexapro®

Back 3

escitalopram

Hint 3

(SSRI) antidepressant

Front 4

Nexium®

Back 4

Esomeprazole

Hint 4

proton pump inhibitor

Front 5

Synthroid®

Back 5

Levothyroxine

Hint 5

thyroid hormone

Front 6

Plavix

Back 6

Clopidogrel

Hint 6

antiplatelet

Front 7

TOPROL-XL®

Back 7

Metoprolol Tartrate

Hint 7

beta-blocker

Front 8

Prevacid®

Back 8

Lansoprazole

Hint 8

GI - antisecretory

Front 9

VYTORIN®

Back 9

Ezetimibe/Simvastatin

Hint 9

antihyperlipidemic

Front 10

Advair Diskus®

Back 10

fluticasone / salmeterol

Hint 10

steroid inhaler/bronchodilator

Front 11

ZYRTEC®

Back 11

Cetirizine hydrochloride

Hint 11

antihistamine

Front 12

Effexor XR®

Back 12

Venlafaxine

Hint 12

antidepressant

Front 13

PROTONIX®

Back 13

Pantoprazole

Hint 13

proton pump inhibitor

Front 14

Diovan®

Back 14

Valsartan

Hint 14

antihypertensive

Front 15

FOSAMAX®

Back 15

Alendronate

Hint 15

osteoporosis

Front 16

ZETIA

Back 16

Ezetimibe

Hint 16

Ezetimibe is an antihyperlipidemic agent.

Front 17

CRESTOR®

Back 17

Rosuvastatin

Hint 17

antihyperlipedemic

Front 18

Levaquin®

Back 18

Levofloxacin

Hint 18

quinolone antibiotic

Front 19

Diovan HCT®

Back 19

Valsartan/Hydrochlorothiazide

Hint 19

antihypertensive/diuretic

Front 20

KLOR-CON®

Back 20

Potassium Chloride Liquid

Hint 20

K+ supplement

Front 21

CYMBALTA®

Back 21

duloxetine hydrochloride

Hint 21

SNRI antidepressants

Front 22

ACTOS®

Back 22

Pioglitazone

Hint 22

thiazolidinedione antidiabetic.

Front 23

Premarin®

Back 23

Conjugated Estrogens

Hint 23

female hormone

Front 24

PROAIR HFA
Inhalation Aerosol

Back 24

Albuterol sulfate

Hint 24

antiasthmatic

Front 25

CELEBREX®

Back 25

Celecoxib

Hint 25

COX-2 inhibitor NSAID.

Front 26

Flomax®

Back 26

Tamsulosin

Hint 26

alpha-blocker (benign prostatic hypertrophy)

Front 27

SEROQUEL®

Back 27

quetiapine fumarate

Hint 27

antipsychotic

Front 28

Norvasc®

Back 28

amlodipine besylate

Hint 28

calcium channel blocker

Front 29

NASONEX®

Back 29

Mometasone furoate monohydrate

Hint 29

antiallergy-steroid

Front 30

TRICOR®

Back 30

fenofibrate

Hint 30

antihyperlipidemic

Front 31

LANTUS®
(insulin glargine [rDNA origin] injection)

Back 31

insulin glargine

Hint 31

antidiabetic

Front 32

VIAGRA®

Back 32

Sildenafil citrate

Hint 32

impotence

Front 33

Altace®

Back 33

Ramipril

Hint 33

angiotensin-converting enzyme (ACE) inhibitor

Front 34

Yasmin®

Back 34

Drospirenone/Ethinyl Estradiol

Hint 34

female contraceptive

Front 35

Levoxyl®

Back 35

levothyroxine

Hint 35

thyroid hormone

Front 36

Adderall XR®

Back 36

Amphetamine

Hint 36

CNS stimulant

Front 37

Lotrel®

Back 37

amlodipine besylate/benazepril hydrochloride

Hint 37

antihypertensive

Front 38

ACTONEL®

Back 38

risedronate sodium

Hint 38

osteoporosis

Front 39

Ambien CR

Back 39

zolpidem tartrate

Hint 39

hypnotic

Front 40

COZAAR®

Back 40

losartan potassium

Hint 40

antihypertensive

Front 41

COREG®

Back 41

carvedilol

Hint 41

beta blocker/antihypertensive

Front 42

VALTREX®

Back 42

valcyclovir hydrochloride

Hint 42

antiviral

Front 43

Lyrica®

Back 43

pregabalin

Hint 43

anticonvulsant and neuropathic pain agent

Front 44

CONCERTA®

Back 44

methylphenidate hcl

Hint 44

CNS stimulant

Front 45

Ambien®

Back 45

zolpidem tartrate

Hint 45

short-term hypnotic

Front 46

RISPERDAL®

Back 46

risperidone

Hint 46

antipsychotic

Front 47

DIGITEK®

Back 47

digoxin

Hint 47

cardiac glycoside

Front 48

TOPAMAX®

Back 48

topiramate

Hint 48

anticonvulsant

Front 49

CHANTIX®

Back 49

varenicline

Hint 49

smoking cessation

Front 50

AVANDIA®

Back 50

rosiglitazone maleate

Hint 50

antidiabetic

Front 51

LAMICTAL®

Back 51

lamotrigine

Hint 51

anticonvulsant

Front 52

ORTHO TRI-CYCLEN®

Back 52

norgestimate/ethinyl estradiol

Hint 52

female oral contraceptive

Front 53

Xalatan®

Back 53

latanoprost

Hint 53

glaucoma

Front 54

ACIPHEX®

Back 54

rabeprazole sodium

Hint 54

GI - antisecretory

Front 55

HYZAAR®

Back 55

losartan/HCTZ

Hint 55

antihypertensive/diuretic

Front 56

Spiriva®
HandiHaler®

Back 56

tiotropium bromide

Hint 56

anticholinergic

Front 57

WELLBUTRIN XL®

Back 57

bupropion hydrochloride

Hint 57

antidepressant

Front 58

LUNESTA®

Back 58

eszopiclone

Hint 58

hypnotic(insomnia)

Front 59

Benicar®

Back 59

olmesartan medoxomil

Hint 59

antihypertensive

Front 60

BENICAR HCT®

Back 60

olmesartan medoxomil-hydrochlorothiazide

Hint 60

antihypertensive - not for initial treatment

Front 61

ARICEPT®

Back 61

donepezil hydrochloride

Hint 61

dementia

Front 62

AVAPRO®

Back 62

irbesartan

Hint 62

angiotension II antagonist

Front 63

Detrol® LA

Back 63

tolterodine tartrate

Hint 63

muscarinic receptor antagonist

Front 64

TriNessa™

Back 64

norgestimate/ethinyl estradiol

Hint 64

female oral contraceptive

Front 65

CIALIS®

Back 65

tadalafil

Hint 65

impotence

Front 66

Combivent®

Back 66

ipratropium bromide/albuterol sulfate

Hint 66

antiasthmatic

Front 67

BUDEPRION XL™

Back 67

bupropion hydrochloride

Hint 67

antidepressant

Front 68

YAZ®

Back 68

drospirenone/ethinyl estradiol

Hint 68

female oral contraceptive

Front 69

Miralax (GlycoLax)

Back 69

Glycolax

Hint 69

laxative

Front 70

IMITREX®

Back 70

sumatriptan succinate

Hint 70

antimigraine

Front 71

EVISTA®

Back 71

raloxifene hydrochloride

Hint 71

osteoporosis

Front 72

NuvaRing®

Back 72

etonogestrel/ethinyl estradiol

Hint 72

female vaginal contraceptive

Front 73

OMNICEF®
(cefdinir) Capsules

Back 73

cefdinir

Hint 73

cephalosporin antibiotic

Front 74

NIASPAN®

Back 74

niacin

Hint 74

vitamin b

Front 75

Tri-Sprintec™

Back 75

norgestimate/ethinyl estradiol

Hint 75

female oral contraceptive

Front 76

BONIVA®

Back 76

ibandronate sodium

Hint 76

osteoporosis/menopause

Front 77

Flovent® HFA

Back 77

fluticasone propionate

Hint 77

antiasthmatic-steroid

Front 78

AVELOX®

Back 78

moxifloxacin hydrochloride

Hint 78

fluoroquinolone antibiotic

Front 79

Abilify®

Back 79

aripiprazole

Hint 79

atypical antipsychotic (Schizophrenia/bipolar)

Front 80

AVALIDE®

Back 80

irbesartan-hydrochlorothiazide

Hint 80

antihypertensive

Front 81

Requip®

Back 81

ropinirole hydrochloride

Hint 81

dopamine receptor agonist

Front 82

ZYRTEC®

Back 82

cetirizine hydrochloride

Hint 82

antihistamine

Front 83

COUMADIN®

Back 83

warfarin sodium

Hint 83

anticoagulant

Front 84

ZYPREXA®

Back 84

olanzapine

Hint 84

antipsychotic

Front 85

Depakote ER®

Back 85

Divalproex

Hint 85

anticonvulsant

Front 86

Nasacort® AQ

Back 86

triamcinolone acetonide

Hint 86

corticosteroid

Front 87

SKELAXIN®

Back 87

metaxalone

Hint 87

muscle relaxant

Front 88

ALLEGRA-D®

Back 88

fexofenadine/pseudoephedrine

Hint 88

antihistamine/decongestant

Front 89

HUMALOG®

Back 89

insulin lispro

Hint 89

antidiabetic

Front 90

VIGAMOX®

Back 90

moxifloxacin hydrochloride 0.5%

Hint 90

fluoroquinolone antibiotic (ophthalmic)

Front 91

ENDOCET®, PERCOCET®

Back 91

oxycodone/acetaminophen

Hint 91

narcotic analgesic

Front 92

BUDEPRION XL™

Back 92

bupropion hydrochloride

Hint 92

antidepressant

Front 93

DEPAKOTE®

Back 93

divalproex sodium

Hint 93

anticonvulsant

Front 94

Namenda®

Back 94

memantine hydrochloride

Hint 94

NMDA-receptor antagonist

Front 95

LIDODERM®
Patch 5%

Back 95

lidocaine 5%

Hint 95

analgesic patch

Front 96

STRATTERA®

Back 96

atomoxetine hydrochloride

Hint 96

controlled CNS stimulant

Front 97

Aviane™-28

Back 97

levonorgestrel/ethinyl estradiol

Hint 97

female oral contraceptive

Front 98

Patanol® 0.1%

Back 98

olopatadine hydrochloride

Hint 98

opthamlmic antihistamine

Front 99

Proventil® HFA

Back 99

albuterol sulfate

Hint 99

antiasthmatic

Front 100

CLARINEX®
(desloratadine) Tablets, Syrup, RediTabs® Tablets

Back 100

desloratadine

Hint 100

antihistamine

Front 101

Armour® Thyroid

Back 101

thyroid

Hint 101

thyroid hormone

Front 102

Astelin®

Back 102

azelastine hydrochloride

Hint 102

antihistamine nasal spray

Front 103

Zyrtec-D®

Back 103

cetirizine HCl/pseudoephedrine HCl

Hint 103

antihistamine/decongestant

Front 104

Tussionex®
Pennkinetic®

Back 104

hydrocodone polistirex/chlorpheniramine polistirex

Hint 104

narcotic antitussive/antihistamine

Front 105

CADUET®

Back 105

amlodipine besylate/atorvastatin calcium

Hint 105

calcium channel blocker/HMG-CoA reductase inhibitor

Front 106

AVODART®

Back 106

dutasteride

Hint 106

5 alpha-reductase enzyme inhibitor (BPH)

Front 107

Keppra®

Back 107

levetiracetam

Hint 107

anticonvulsant

Front 108

JANUVIA™

Back 108

sitagliptin

Hint 108

dipeptidyl peptidase-4 (DPP-4) inhibitor

Front 109

Kariva™

Back 109

desogestrel/ethinyl estradiol and ethinyl estradiol

Hint 109

female oral contraceptive

Front 110

PREMPRO™
(conjugated estrogens/medroxyprogesterone acetate) Tablets

PREMPHASE®
(conjugated estrogens/medroxyprogesterone acetate) Tablets

Back 110

PREMPRO or PREMPHASE therapy is indicated in women who have a uterus for the:

1. Treatment of moderate to severe vasomotor symptoms due to menopause.
2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
3. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate.

Front 111

RHINOCORT AQUA
Nasal Spray 32 mcg

Back 111

budesonide

Hint 111

corticosteroid

Front 112

LEVITRA®

Back 112

vardenafil hcl

Hint 112

impotence

Front 113

ORTHO EVRA®
Transdermal System

Back 113

norelgestromin/ ethinyl estradiol

Hint 113

female transdermal contraceptive

Front 114

Low-Ogestrel®
(norgestrel and ethinyl estradiol) Tablets USP, 0.3 mg/0.03 mg

Back 114

Low-Ogestrel® (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

Front 115

Vivelle-Dot®
(estradiol transdermal system)

Back 115

Vivelle-Dot® (estradiol transdermal system) is indicated in:

1. Treatment of moderate to severe vasomotor symptoms associated with the menopause.
2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
3. Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure.
4. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered.

Front 116

Apri
(desogestrel and ethinyl estradiol) Tablets

Back 116

Apri (desogestrel and ethinyl estradiol) Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Front 117

Loestrin® 24 Fe
(norethindrone acetate and ethinyl estradiol) Tablets, USP and (ferrous fumarate) Tablets
Ferrous fumarate tablets are not USP for dissolution and assay.

Back 117

Loestrin 24 Fe is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Front 118

LEVOTHROID®

Back 118

levothyroxine sodium

Hint 118

thyroid hormone

Front 119

Necon® 1/35
(norethindrone and ethinyl estradiol) Tablets USP

Necon® 0.5/35
(norethindrone and ethinyl estradiol) Tablets USP

Necon® 10/11
(norethindrone and ethinyl estradiol) Tablets USP

Necon® 1/50
(norethindrone and mestranol) Tablets USP

Back 119

Necon® 1/35, Necon® 0.5/35, Necon® 10/11, and Necon® 1/50 are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

Front 120

FOSAMAX PLUS D™
(alendronate sodium/cholecalciferol) Tablets

Back 120

FOSAMAX PLUS D is indicated for:
Treatment of Osteoporosis in Postmenopausal Women

For the treatment of osteoporosis, FOSAMAX PLUS D increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures).
Treatment to Increase Bone Mass in Men with Osteoporosis
Important Limitations of Use

FOSAMAX PLUS D alone should not be used to treat vitamin D deficiency.

Front 121

BYETTA®
(exenatide) Injection

Back 121

BYETTA is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, a thiazolidinedione, a combination of metformin and a sulfonylurea, or a combination of metformin and a thiazolidinedione, but have not achieved adequate glycemic control.

Front 122

Pulmicort Respules®
(budesonide) Inhalation Suspension 0.25 mg, 0.5 mg, and 1 mg

Back 122

PULMICORT RESPULES is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age.

PULMICORT RESPULES is NOT indicated for the relief of acute bronchospasm.

Front 123

Paxil CR®
(paroxetine hydrochloride) Controlled-Release Tablets

Back 123

Major Depressive Disorder: PAXIL CR is indicated for the treatment of major depressive disorder.

Front 124

Glucotrol XL®
(glipizide) Extended Release Tablets

Back 124

GLUCOTROL XL is indicated as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with type 2 diabetes formerly known as non-insulin-dependent diabetes mellitus (NIDDM) or maturity-onset diabetes, after an adequate trial of dietary therapy has proved unsatisfactory.

Front 125

PROVIGIL®
(modafinil) Tablets [C-IV]

Back 125

PROVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder.

Front 126

TRILEPTAL®
(oxcarbazepine) Tablets & Oral Suspension

Back 126

Trileptal® (oxcarbazepine) is indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and as monotherapy in the treatment of partial seizures in children aged 4 years and above with epilepsy, and as adjunctive therapy in children aged 2 years and above with epilepsy.

Front 127

HUMULIN® N
(NPH HUMAN INSULIN (rDNA ORIGIN) ISOPHANE SUSPENSION, 10 mL Vial (1000 Units per vial), 100 UNITS PER ML (U-100))

Back 127

for insulin therapy and diabetes control

Front 128

LUMIGAN®
(bimatoprost) Ophthalmic Solution 0.03%

Back 128

LUMIGAN® (bimatoprost ophthalmic solution) 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Front 129

ALPHAGAN® P
(brimonidine tartrate) Ophthalmic Solution) 0.1% and 0.15%

Back 129

ALPHAGANÒ P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Front 130

XOPENEX HFA™
(levalbuterol tartrate) Inhalation Aerosol For Oral Inhalation Only

Back 130

XOPENEX HFA (levalbuterol tartrate) Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.

Front 131

Tobradex®
(tobramycin and dexamethasone ophthalmic) Suspension Sterile

Back 131

TOBRADEX (tobramycin and dexamethasone ophthalmic suspension) is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.

Front 132

Trivora-28
(levonorgestrel and ethinyl estradiol)

Back 132

Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

Front 133

ATACAND
(candesartan cilexetil) Tablets

Back 133

Hypertension

ATACAND is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
Heart Failure

ATACAND is indicated for the treatment of heart failure (NYHA class II-IV) in patients with left ventricular systolic dysfunction (ejection fraction ≤ 40%) to reduce cardiovascular death and to reduce heart failure hospitalizations.

Front 134

Xopenex®
(levalbuterol HCl) Inhalation Solution, 0.31 mg*, 0.63 mg*, 1.25 mg*

Back 134

Xopenex (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 yearsof age and older with reversible obstructive airway disease.

Front 135

COSOPT®
(dorzolamide hydrochloride-timolol maleate) Sterile Ophthalmic Solution

Back 135

COSOPT is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time).

Front 136

GEODON®
(ziprasidone HCl) Capsules

GEODON®
(ziprasidone mesylate) for Injection

Back 136

Schizophrenia

Ziprasidone is indicated for the treatment of schizophrenia. When deciding among the alternative treatments available for this condition, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs.

Bipolar Mania

Ziprasidone is indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features.

Acute Agitation in Schizophrenic Patients

Ziprasidone intramuscular is indicated for the treatment of acute agitation in schizophrenic patients for whom treatment with ziprasidone is appropriate and who need intramuscular antipsychotic medication for rapid control of the agitation.

Front 137

Micardis®
(telmisartan) Tablets, 20 mg, 40 mg and 80 mg

Back 137

MICARDIS (telmisartan) is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Front 138

LOVAZA®
(omega-3-acid ethyl esters) Capsules

Back 138

Very High Triglycerides

LOVAZA is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with very high ( > 500 mg/dL) triglyceride levels.

Front 139

Micardis® HCT
(telmisartan and hydrochlorothiazide) Tablets, 40 mg/12.5 mg 80 mg/12.5 mg and 80 mg/25 mg

Back 139

MICARDIS HCT (telmisartan/hydrochlorothiazide) is indicated for the treatment of hypertension.

Front 140

Focalin® XR
(dexmethylphenidate hydrochloride) Extended-Release Capsules

Back 140

Focalin® XR (dexmethylphenidate hydrochloride) extended-release capsules is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older.

Front 141

OXYCONTIN®
(oxycodone HCl) Controlled Release Tablets 10 mg 20 mg 40 mg 80 mg* 160 mg*

Back 141

OxyContin Tablets are a controlled-release oral formulation of oxycodone hydrochloride indicated for the management of moderate to severe pain when a continuous, around-the­clock analgesic is needed for an extended period of time.

Front 142

Mirapex®
(pramipexole dihydrochloride) 0.125 mg, 0.25 mg, 0.5 mg, 1 mg, and 1.5 mg Tablets

Back 142

Parkinson's Disease

MIRAPEX (pramipexole dihydrochloride) tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease.

Restless Legs Syndrome

MIRAPEX tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

Front 143

PROMETRIUM®
(progesterone) USP Capsules 100, Capsules 200 mg

Back 143

PROMETRIUM Capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets.

Front 144

HUMULIN® 70/30
(70% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN) 10 mL Vial (1000 Units per vial) 100 UNITS PER ML (U-100))

Back 144

Used for insulin therapy and diabetes control.

Front 145

CIPRODEX®
(ciprofloxacin 0.3% and dexamethasone 0.1%)
Sterile Otic Suspension

Back 145

CIPRODEX® Otic is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below:

Acute Otitis Media in pediatric patients (age 6 months and older) with tympanostomy tubes due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Pseudomonas aeruginosa.

Acute Otitis Externa in pediatric (age 6 months and older), adult and elderly patients due to Staphylococcus aureus and Pseudomonas aeruginosa.

Front 146

RESTASIS®
(cyclosporine) Ophthalmic Emulsion 0.05%

Back 146

RESTASIS® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.

Front 147

SUBOXONE
(buprenorphine HCI and naloxone HCI dihydrate sublingual) Tablets

SUBUTEX
(buprenorphine HO sublingual) Tablets

Back 147

SUBOXONE and SUBUTEX are indicated for the treatment of opioid dependence.

Front 148

ZYMAR®
(gatifloxacin ophthalmic solution) 0.3%
sterile

Back 148

ZYMAR® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Aerobic Gram-Positive Bacteria:

Cornyebacterium propinquum*
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus mitis*
Streptococcus pneumoniae

Aerobic Gram-Negative Bacteria:

Haemophilus influenzae

Front 149

ARIMIDEX®
anastrozole Tablets

Back 149

ARIMIDEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

ARIMIDEX is indicated for the first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.

ARIMIDEX is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to ARIMIDEX.

Front 150

Sprintec™
(norgestimate and ethinyl estradiol) Tablets

Back 150

Sprintec Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Front 151

Dilantin®
KAPSEALS®
(extended phenytoin sodium) Capsules, USP

Back 151

Dilantin is indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.

Front 152

Fluzone®
Influenza Virus Vaccine

Back 152

Fluzone vaccine is indicated for active immunization against influenza disease caused by influenza virus types A and B contained in the vaccine in subjects from 6 months of age and older.

Front 153

BenzaClin® Topical Gel
(clindamycin - benzoyl peroxide gel)

Back 153

BenzaClin Topical Gel is indicated for the topical treatment of acne vulgaris.

Front 154

VESIcare®
(solifenacin succinate) Tablets

Back 154

VESIcare is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Front 155

Asacol®
(mesalamine) Delayed-Release Tablets

Back 155

Asacol tablets are indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.

Front 156

AVANDAMET®
(rosiglitazone maleate and metformin hydrochloride) Tablets

Back 156

AVANDAMET is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus when treatment with dual rosiglitazone and metformin therapy is appropriate.

Front 157

LANOXIN®
(digoxin injection 500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL)

Back 157

Heart Failure: LANOXIN is indicated for the treatment of mild to moderate heart failure. LANOXIN increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, LANOXIN should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified.

Atrial Fibrillation: LANOXIN is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation.

Front 158

Travatan
(travoprost ophthalmic solution) 0.004% Sterile

Back 158

TRAVATAN® Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication.

Front 159

ZOLOFT®
(sertraline hydrochloride) Tablets and Oral Concentrate

Back 159

Major Depressive Disorder-ZOLOFT (sertraline hydrochloride) is indicated for the treatment of major depressive disorder in adults.

Front 160

TAMIFLU®
(oseltamivir phosphate) Capsules And For Oral Suspension

Back 160

Treatment of Influenza

TAMIFLU is indicated for the treatment of uncomplicated acute illness due to influenza infection in patients 1 year and older who have been symptomatic for no more than 2 days.
Prophylaxis of Influenza

TAMIFLU is indicated for the prophylaxis of influenza in patients 1 year and older.

The following points should be considered before initiating treatment or prophylaxis with

TAMIFLU:

* TAMIFLU is not a substitute for early vaccination on an annual basis as recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices.
* Influenza viruses change over time. Emergence of resistance mutations could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use TAMIFLU.

Front 161

BACTROBAN NASAL®
(mupirocin calcium) Ointment, 2%

for intranasal use only

Back 161

BACTROBAN NASAL is indicated for the eradication of nasal colonization with methicillin-resistant S. aureus in adult patients and health care workers as part of a comprehensive infection control program to reduce the risk of infection among patients at high risk of methicillin-resistant S. aureus infection during institutional outbreaks of infections with this pathogen.

Front 162

DIFFERIN®
(adapalene) Gel, 0.3%
For topical use only. Not for ophthalmic, oral or intravaginal use

Back 162

DIFFERIN Gel, 0.3% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

Front 163

Guaifenex® PSE 60
(guaifenesin/pseudoephedrine) Extended-release Tablets Expectorant/Nasal Decongestant

Back 163

Guaifenex® PSE 60 Extended-release Tablets are indicated for the temporary relief of nasal congestion and cough associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis, and asthma, when these conditions are complicated by tenacious mucous and/or mucous plugs and congestion. The product is effective in productive as well as non-productive cough, but is of particular value in dry, non-productive cough which tends to injure the mucous membrane of the air passages.

Front 164

PREMARIN
(conjugated estrogens) Vaginal Cream

Back 164

Treatment of Atrophic Vaginitis and Kraurosis Vulvae
Treatment of Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy, due to Menopause Health Initiative (WHI) estrogen-alone substudy

Front 165

Pseudovent™ 400
(pseudoephedrine HCl [extended-release]/ guaifenesin) Capsules

Back 165

This product is indicated for temporary relief of symptoms due to upper respiratory tract disorders such as nasal congestion, sinusitis, vasomotor rhinitis and hay fever; as well as for the temporary relief of coughs associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis, and asthma, when these conditions are complicated by tenacious mucus and/or mucus plugs and congestion. This product is effective in a productive as well as a nonproductive cough, but is of particular value in a dry, nonproductive cough which tends to injure themucous membrane of the air passages.

Front 166

Vagifem®
(estradiol vaginal) Tablets

Back 166

VAGIFEM® is indicated for the treatment of atrophic vaginitis.

Front 167

Levora
(levonorgestrel and ethinyl estradiol)

Back 167

Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

Front 168

RELPAX®
(eletriptan hydrobromide) Tablets

Back 168

RELPAX®
(eletriptan hydrobromide) is indicated for the acute treatment of migraine with or without aura in adults.

Front 169

ALLEGRA-D® 24 HOUR
(fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg) Extended-Release Tablets

Back 169

ALLEGRA-D 24 HOUR Extended-Release Tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. Symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion.

ALLEGRA-D 24 HOUR should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired.

Front 170

Methylin® Chewable Tablets
(methylphenidate HCl) Chewable Tablets 2.5 mg, 5 mg and 10 mg

Back 170

Attention Deficit Disorders, Narcolepsy

Attention Deficit Disorders (previously known as Minimal Brain Dysfunction in Children). Other terms being used to describe the behavioral syndrome below include: Hyperkinetic Child Syndrome, Minimal Brain Damage, Minimal Cerebral Dysfunction, Minor Cerebral Dysfunction.

Front 171

AndroGel®
(testosterone gel) 1% for topical use

Back 171

Testosterone Replacement Therapy

AndroGel, an androgen, is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:

Front 172

Aggrenox
(aspirin/extended-release dipyridamole) 25 mg/200 mg capsules

Back 172

Aggrenox (aspirin/extended-release dipyridamole) capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

Front 173

PROPECIA®
(finasteride) Tablets, 1 mg

Back 173

PROPECIA is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY.

Front 174

ASMANEX® TWISTHALER® 220 mcg
(mometasone furoate) Inhalation Powder

ASMANEX® TWISTHALER® 110 mcg
(mometasone furoate) Inhalation powder

FOR ORAL INHALATION ONLY

Back 174

Treatment of Asthma

ASMANEX® TWISTHALER® is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older.

Front 175

NovoLog® Mix 70/30
(70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])

Back 175

NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia.

Front 176

UROXATRAL®
(alfuzosin HCl) Extended-Release Tablets

Back 176

UROXATRAL (alfuzosin HCl extended-release tablets) is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia. UROXATRAL is not indicated for the treatment of hypertension.

Front 177

Estrostep®Fe
(norethindrone acetate and ethinyl estradiol) Tablets, USP and (ferrous fumarate) Tablets*
*Ferrous fumarate tablets are not USP for dissolution and assay.

Back 177

ESTROSTEP Fe is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Front 178

Sular
(nisoldipine) Extended Release Tablets

Back 178

SULAR is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Front 179

Lescol®
(fluvastatin sodium) Capsules
Lescol® XL
(fluvastatin sodium) Extended-Release Tablets

Back 179

Lescol® (fluvastatin sodium) and Lescol® XL (fluvastatin sodium) are indicated to reduce elevated total cholesterol (Total-C), LDL-C, TG and Apo B levels, and to increase HDL-C in patients with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Type IIa and IIb) whose response to dietary restriction of saturated fat and cholesterol and other nonpharmacological measures has not been adequate.

Front 180

NovoLog® Mix 70/30
(70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])

Back 180

NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia.

Front 181

EPIPEN®
(epinephrine) Auto-Injector 0.3 mg
EpiPen® = one dose of 0.30 mg epinephrine (USP, 1:1000, 0.3 mL)

EPIPEN® JR
(epinephrine) Auto-Injector 0.15 mg
EpiPen® Jr = one dose of 0.15 mg epinephrine (USP, 1:2000, 0.3 mL)

Back 181

EpiPen® and EpiPen® Jr Auto-Injectors are indicated in the emergency treatment of allergic reactions

Front 182

ACTOPLUS MET®
(pioglitazone hydrochloride and metformin hydrochloride) Tablets

Back 182

ACTOPLUS MET is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are already treated with a combination of pioglitazone and metformin or whose diabetes is not adequately controlled with metformin alone, or for those patients who have initially responded to pioglitazone alone and require additional glycemic control.

Front 183

M-Oxy (oxycodone)

Back 183

M-Oxy (oxycodone) is used to treat moderate to severe pain.

Front 184

ROZEREM
(ramelteon) Tablets

Back 184

ROZEREM
(ramelteon) Tablets

Front 185

ENABLEX®
(darifenacin) Extended-Release Tablets

Back 185

ENABLEX® (darifenacin) extended-release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.

Front 186

JANTOVEN® TABLETS
(warfarin sodium) Tablets, USP

Back 186

Jantoven® Tablets (Warfarin Sodium Tablets, USP) are indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism.

Jantoven® Tablets are indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement.

Jantoven® Tablets are indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

Front 187

Catapres-TTS
(clonidine)

Catapres-TTS -1
Catapres-TTS -2
Catapres-TTS -3

Back 187

Catapres-TTS® (clonidine) transdermal therapeutic system is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.

Front 188

Junel™ 21 Day
(norethindrone acetate and ethinyl estradiol) Tablets, USP
Junel™ Fe 28 Day
(norethindrone acetate and ethinyl estradiol) Tablets, USP and (ferrous fumarate) Tablets*

*Ferrous fumarate tablets are not USP for dissolution and assay.

Junel™ 1/20
(Each light yellow tablet contains 1 mg norethindrone acetate and 20 mcg ethinyl estradiol.)
Junel™ 1.5/30
(Each pink tablet contains 1.5 mg norethindrone acetate and 30 mcg ethinyl estradiol.)
Junel™ Fe 1/20
(Each light yellow tablet contains 1 mg norethindrone acetate and 20 mcg ethinyl estradiol. Each brown tablet contains 75 mg ferrous fumarate.)
Junel™ Fe 1.5/30
(Each pink tablet contains 1.5 mg norethindrone acetate and 30 mcg ethinyl estradiol. Each brown tablet contains 75 mg ferrous fumarate.)

Back 188

Junel™ 21 and Junel™ Fe 28 are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Front 189

COREG CR™
(carvedilol phosphate) Extended-Release Capsules

Back 189

Heart Failure: COREG CR is indicated for the treatment of mild-to-severe heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitor, and digitalis, to increase survival and, also, to reduce the risk of hospitalization

Left Ventricular Dysfunction Following Myocardial Infarction: COREG CR is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤ 40% (with or without symptomatic heart failure)

Front 190

Ortho Tri-Cyclen® Tablets
Ortho-Cyclen® Tablets
(norgestimate/ethinyl estradiol)

Back 190

ORTHO-CYCLEN® and ORTHO TRI-CYCLEN® Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Front 191

PrimaCare® ONE (A once-daily prenatal vitamin supplement, including key omega-3 fatty acids (DHA and EPA) and 1 mg folic acid)

Back 191

PrimaCare® ONE is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. It is also useful for improving nutritional status prior to conception.

Front 192

ZOVIRAX®
(acyclovir) Ointment 5%

Back 192

ZOVIRAX (acyclovir) Ointment 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous Herpes simplex virus infections in immunocompromised patients.

Front 193

TriLyte® with flavor packs
(PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution)

Back 193

TriLyte® with flavor packs is indicated for bowel cleansing prior to colonoscopy.

Front 194

Aldara™
(imiquimod) Cream

Back 194

Actinic Keratosis

Aldara Cream is indicated for the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults.
Superficial Basal Cell Carcinoma

Aldara Cream is indicated for the topical treatment of biopsy-confirmed, primary superficial basal cell carcinoma (sBCC) in immunocompetent adults, with a maximum tumor diameter of 2.0 cm, located on the trunk (excluding anogenital skin), neck, or extremities (excluding hands and feet), only when surgical methods are medically less appropriate and patient follow-up can be reasonably assured.

The histological diagnosis of superficial basal cell carcinoma should be established prior to treatment, since safety and efficacy of Aldara Cream have not been established for other types of basal cell carcinomas, including nodular and morpheaform (fibrosing or sclerosing) types.
External Genital Warts

Aldara Cream is indicated for the treatment of external genital and perianal warts/condyloma acuminata in patients 12 years or older.

Front 195

Necon® 1/35
(norethindrone and ethinyl estradiol) Tablets USP

Necon® 0.5/35
(norethindrone and ethinyl estradiol) Tablets USP

Necon® 10/11
(norethindrone and ethinyl estradiol) Tablets USP

Necon® 1/50
(norethindrone and mestranol) Tablets USP

Back 195

Necon® 1/35, Necon® 0.5/35, Necon® 10/11, and Necon® 1/50 are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

Front 196

ARTHROTEC®
(diclofenac sodium/misoprostol) Tablets

Back 196

ARTHROTEC is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications.

Front 197

ULTRAM® ER
(tramadol HCl) Extended-Release Tablets

Back 197

ULTRAM ER is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

Front 198

CERON-DM (dextromethorphan, decongestant, antihistamine)

Back 198

This combination medication is used to treat symptoms caused by the common cold, flu, allergies, hay fever, or other breathing illnesses (e.g., sinusitis, bronchitis). Dextromethorphan is a cough suppressant that affects a certain part of the brain (cough center), reducing the urge to cough. Decongestants help relieve stuffy nose symptoms. Antihistamines relieve watery eyes, itchy eyes/nose/throat, runny nose, and sneezing.

Front 199

EtheDent™
1.1% SODIUM FLUORIDE
(Sodium Fluoride, USP) Prescription Dental Cream

Back 199

A dental caries preventive; for once daily self-applied topical use. It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.

Front 200

Elidel®
(pimecrolimus) Cream 1%

Back 200

ELIDEL® (pimecrolimus) Cream 1% is indicated as second-line therapy for the short- term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non- immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable.